Our study found that if Medicare purchased urologic drugs through Mark Cuban's Cost Plus Drug Company, we would save taxpayers an estimated $1.29 billion.
It means that patients, regardless of what kind of insurance they have, whether it's Medicare, whether they're self-insured, or they get insurance through their employer, can get drugs at a way more affordable rate than what we previously thought.